Please Wait

Applying Filters...

Seqens

Seqens

X

Looking for Tox21_300537? Find Controlled & Modified Release used in Tox21_300537 to address drug delivery challenges on PharmaCompass.

Product

Filters

FILTER :

filter Company

All (3)

01 Gangwal Healthcare (2)

02 Kerry (1)

filter Capability

All (3)

01 Capsule (1)

02 Tablet (2)

filter Country

All (3)

01 India (2)

02 U.S.A (1)

price-trend

Gangwal Healthcare

Contact Supplier

Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Contact Supplier

Contact Supplier

Digital Content

DICOM-DC® SR300

PDF Supplier PDF

URL Supplier Web Content

LM Application #LearnMore

Applications:

DiCOM-DC® SR300 is co-processed excipient with a combination of various rate controlling polymers that act as fillers and binders. SR300 is used in sustained-release formulations.

Ingredient(s): EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc

Dosage Form: Capsule, Tablet

Category: Co-Processed Excipients, Controlled & Modified Release, Fillers, Diluents & Binders

Route of Administration (Grade): Oral

Pharmacopoeia Reference: In-house

Technical Specifications: NA

Gangwal Healthcare DiCOM-DC® SR300

Iran Expo

Not Confirmed

envelop

Contact Supplier

Kerry

Contact Supplier

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Post an Enquiry

Digital Content

SHEFFCOAT™ S

PDF Supplier PDF

URL Supplier Web Content

LM Application #LearnMore

Applications:

Immediate Release

Ingredient(s): Hydroxypropyl Methylcellulose, Starch

Dosage Form: Tablet

Category: Coating Systems & Additives, Controlled & Modified Release

Route of Administration (Grade): Not Available

Pharmacopoeia Reference: Customized per requirements

Technical Specifications: Not Available

ASK
US

Upload
your Marketing & Sales content

POST ENQUIRY